Cytisine for Smoking Cessation
ClinicalTrials.gov Identifier: NCT05729243 Recruitment Status : Not yet recruiting First Posted : February 15, 2023 Last Update Posted : February 15, 2023 See Contacts and Locations View this study on Beta.ClinicalTrials.gov Brief Summary: The goal of this clinical...
Cytisine and E-cigarettes With Supportive Text-messaging for Smoking Cessation (Cess@Tion)
ClinicalTrials.gov Identifier: NCT05311085 Recruitment Status : Not yet recruiting First Posted : April 5, 2022 Last Update Posted : April 5, 2022 See Contacts and Locations Brief Summary: This research focuses on maximizing the benefits of proven smoking cessation...
A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers
ClinicalTrials.gov Identifier: NCT05206370 Recruitment Status : Not yet recruiting First Posted : January 25, 2022 Last Update Posted : January 25, 2022 See Contacts and Locations Brief Summary: This placebo-controlled Phase 3 study is being conducted at sites within...
Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)
ClinicalTrials.gov Identifier: NCT02585024 Recruitment Status : Terminated First Posted : October 23, 2015 Last Update Posted : March 22, 2019 Brief Summary: A number of pharmacotherapies are available for smoking cessation in New Zealand including nicotine...
Cytisine Versus Varenicline for Smoking Cessation
ClinicalTrials.gov Identifier: NCT02957786 Recruitment Status : Completed First Posted : November 8, 2016 Last Update Posted : May 27, 2020 Brief Summary: To evaluate the effectiveness, safety, and cost-effectiveness of cytisine plus behavioural support compared to...
A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine
ClinicalTrials.gov Identifier: NCT03268343 Recruitment Status : Completed First Posted : August 31, 2017 Results First Posted : February 7, 2019 Last Update Posted : February 26, 2019 Brief Summary: This will be an open-label, randomised, 2-period, single-dose...
A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers
ClinicalTrials.gov Identifier: NCT03303911 Recruitment Status : Terminated (It has been difficult to recruit participants meeting study entry criteria that are >65 years of age and not for any safety reasons.) First Posted : October 6, 2017 Results First Posted :...
A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation
ClinicalTrials.gov Identifier: NCT03509948 Recruitment Status : Completed First Posted : April 27, 2018 Results First Posted : September 12, 2019 Last Update Posted : September 24, 2019 Brief Summary: This will be an open-label, randomised, 2-treatment period,...
Trial of Cytisine in Adult Smokers
ClinicalTrials.gov Identifier: NCT03709823 Recruitment Status : Completed First Posted : October 17, 2018 Results First Posted : May 18, 2020 Last Update Posted : May 18, 2020 Brief Summary: This placebo-controlled Phase 2b trial is being conducted at sites within the...
A Single Dose-escalation Study of Cytisine in Adult Smokers
ClinicalTrials.gov Identifier: NCT03848208 Recruitment Status : Completed First Posted : February 20, 2019 Results First Posted : September 17, 2020 Last Update Posted : September 17, 2020 Brief Summary: The objectives of this study are: To assess the tolerability and...
Zacks Small Cap Research – ACHV: RAUORA: Cytisinicline’s Superior Side Effect Profile
By John Vandermosten, CFA NASDAQ:ACHV On Monday, Achieve Life Sciences, Inc. (NASDAQ:ACHV) updated the investment community on the status of New Zealand’s RAUORA1 study, which was expected to announce completion in the months leading up to the September SRNT...
Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting
ClinicalTrials.gov Identifier: NCT04015414 Recruitment Status : Recruiting First Posted : July 11, 2019 Last Update Posted : August 10, 2020 See Contacts and Locations Brief Summary: The overall goals of this study are to 1) assess awareness of interest in the use of...